Does the use of E Panta L lead to increased risk of fractures?
Nov 5, 2023
Does the use of E Panta L lead to increased risk of fractures?
Numerous studies conducted on adults have revealed a potential association between the use of E Panta L and an increased risk of fractures related to osteoporosis particularly in the hip wrist and spine The elevated risk of experiencing fractures was found to be more significant among patients who were administered high doses of this medication High doses in this context refer to the administration of multiple daily doses over an extended period of time typically lasting a year or longer These findings emphasize the importance of considering the potential risks associated with longterm therapy involving E Panta L especially in individuals who may be susceptible to osteoporosisrelated fractures It is crucial for healthcare professionals and patients alike to be cautious and wellinformed when making decisions regarding the usage and duration of E Panta L treatment taking into account the potential risks involved to ensure the overall wellbeing and safety of the patients